News

2007 Press Releases

October 18, 2007
Advaxis, Inc. Completes $9.4 Million Equity Financing

October 9, 2007
Advaxis, Inc. Phase I/II Results of Lovaxin C in Cervical Cancer Study Released

April, 2007
Advaxis Completes Dosing and Enrollment of Third Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial

March 15, 2007
Two Leading Biotech Publications Report on Advaxis’ Listeria Platform Technology

March 2, 2007
Recent HPV Findings by Centers for Disease Control and Prevention Validate Advaxis, Inc.'s Treatable Population

Home